FAQ

Growth Hormone-Releasing Hormone Analogue

Known as: GRF Analog, GHRF Analog, Somatocrinin Analogue 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2018
0246819932018

Related topics

Related topics

1 relation
Growth Hormone Releasing Factor Analog [EPC]

Related mentions per year

Related mentions per year

1984-2018
19801990200020102020
Growth Hormone-Releasing Hormone Analogue
Growth Hormone Releasing Factor Analog [EPC]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers.
OBJECTIVE Activation of ghrelin receptors stimulates GH secretion and appetite, increasing lean body mass and body weight… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2009
2009
Fluorine and rhenium substituted ghrelin analogues as potential imaging probes for the growth hormone secretagogue receptor.
In our effort to create imaging probes targeting the growth hormone secretagogue receptor (GHSR), we now report on the design and… (More)
  • figure 2
  • table 1
  • figure 3
  • table 2
  • table 3
Is this relevant?
2008
2008
Inhibition of proliferation and apoptosis of vascular smooth muscle cells by ghrelin.
To evaluate the possible role of ghrelin in the development of atherosclerosis, its effects on tumor necrosis factor (TNF)-alpha… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in rat.
Abnormal growth of cardiac fibroblasts is critically involved in the pathophysiology of cardiac hypertrophy/remodeling. Hexarelin… (More)
Is this relevant?
2005
2005
Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.
OBJECTIVE AND METHODS Quantitative analysis of mRNA expression of ghrelin and its receptors GHS-R1a and -R1b in a large series of… (More)
Is this relevant?
2003
2003
New active series of growth hormone secretagogues.
New growth hormone secretagogue (GHS) analogues were synthesized and evaluated for growth hormone releasing activity. This series… (More)
Is this relevant?
2002
2002
Discovery and biological characterization of capromorelin analogues with extended half-lives.
New tert-butyl, picolyl and fluorinated analogues of capromorelin (3), a short-acting growth hormone secretagogue (GHS), were… (More)
Is this relevant?
2001
2001
Treatment with a growth hormone secretagogue in a model of developing heart failure: effects on ventricular and myocyte function.
BACKGROUND Exogenous administration of growth hormone (GH) and subsequently increased production of insulin-like growth factor-1… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
2001
2001
Pharmacological profile of a new orally active growth hormone secretagogue, SM-130686.
SM-130686, an oxindole derivative, is a novel orally active GH secretagogue (GHS) which is structurally distinct from previously… (More)
Is this relevant?
1998
1998
MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
The reversal of diet-induced negative nitrogen balance by GH suggests a possible therapeutic role for GH treatment in catabolic… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?